OnabotulinumtoxinA for the prevention of chronic migraine in adolescents: the experience of an italian third level headache center

被引：0
|
作者：
Frattale, I. [1 ]
Ursitti, F. [1 ]
Sforza, G. [1 ]
Monte, G. [1 ]
Ferilli, M. A. N. [1 ]
Tarantino, S. [1 ]
Checchi, M. Proietti [1 ]
Valeriani, M. [1 ]
Papetti, L. [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Dev Neurol Unit, Rome, Italy
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P157
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
    Bendtsen, Lars
    Sacco, Simona
    Ashina, Messoud
    Mitsikostas, Dimos
    Ahmed, Fayyaz
    Pozo-Rosich, Patricia
    Martelletti, Paolo
    JOURNAL OF HEADACHE AND PAIN, 2018, 19 : 91
  • [42] Non-headache benefits of onabotulinumtoxinA in chronic migraine patients: PREEMPT pooled analysis
    Diener, Hans-Christoph
    Lipton, Richard B.
    Dodick, David W.
    DeGryse, Ronald E.
    Adams, Aubrey Manack
    Silberstein, Stephen D.
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 403 - 404
  • [43] Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
    Lars Bendtsen
    Simona Sacco
    Messoud Ashina
    Dimos Mitsikostas
    Fayyaz Ahmed
    Patricia Pozo-Rosich
    Paolo Martelletti
    The Journal of Headache and Pain, 2018, 19
  • [44] Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks
    A. Oterino
    C. Ramón
    J. Pascual
    The Journal of Headache and Pain, 2011, 12 : 235 - 238
  • [45] Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
    Gago-Veiga, A. B.
    Santos-Lasaosa, S.
    Cuadrado, M. L.
    Guerrero, A. L.
    Irimia, P.
    Lainez, J. M.
    Leira, R.
    Pascual, J.
    Sanchez del Rio, M.
    Viguera, J.
    Pozo-Rosich, P.
    NEUROLOGIA, 2019, 34 (06): : 408 - 417
  • [46] Experience with onabotulinumtoxina (BOTOX) in chronic refractory migraine: focus on severe attacks
    Pascual, J.
    Oterino, A.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S33 - S33
  • [47] Is Less More? a Retrospective Review of Pediatric and Adolescent Migraine Management with OnabotulinumtoxinA at a Pediatric Headache Center
    Pezzuto, T. A.
    HEADACHE, 2018, 58 : 156 - 157
  • [48] Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
    Torres-Ferrus, Marta
    Gallardo, Victor Jose
    Alpuente, Alicia
    Pozo-Rosich, Patricia
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [49] Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
    Marta Torres-Ferrus
    Victor José Gallardo
    Alicia Alpuente
    Patricia Pozo-Rosich
    The Journal of Headache and Pain, 2020, 21
  • [50] Anti-CGRP antibodies efficacy in Chronic Migraine: an italian tertiary center experience
    Maccabeo, A.
    Corda, D.
    Pinna, F.
    Solla, P.
    D'Onofrio, M.
    Defazio, G.
    Zoroddu, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 421 - 421
12345